Delivery Order SPE2DB22D3501-SPE2DB25FUS90

Award Date 2/27/25
Potential Completion Date 3/20/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $20,908.66, is for the delivery of POLIVY 140 MG vials to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
This is a $10,454.32 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, part of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of POLIVY 140 MG VIALS, a pharmaceutical product, with a performance period ending on May 22, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company, and holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564288200 POLIVY 140 MG VIALS to the U.S. government. The contract, valued at $40,304.38, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
This federal contract award, with the ID SPE2DB22D2206|SPE2DB25FFE63, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567007103 | POLIVY 140 MG VIALS, a pharmaceutical product. The contract has a ceiling value of $11,023.03, a firm fixed price pricing type, and an ultimate completion date of February 12, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, valued at $1,707.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award is for the procurement of IPOL VIAL 5ML medical products by the Defense Logistics Agency (DLA) from Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,509.23 delivery order contract has an ultimate completion date of May 18, 2023 and was awarded on May 17, 2023. The contract is a firm fixed price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,409.43, is for the delivery of IPOL vial 5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 27, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
The U.S. Department of Defense awarded a $59,335.20 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a completion date of October 2, 2023, is for the delivery of 4562356439 IPOL VIAL 5ML medical supplies. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, which provides a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,150.53, is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract is a firm fixed-price delivery order with a completion date of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of 4564628204 IPOL VIAL 5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $10,673.50, and an ultimate completion date of May 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUS90
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,023.03, is for the delivery of POLIVY 140 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have any set-aside designations, indicating open competition.

Generated 6/1/25, 3:11 AM